Table 1.
Code | Formula | Cut-off point | Cohort used as reference population | Referencea | ||
---|---|---|---|---|---|---|
Sarcopenia present | Men | Women | ||||
A | ALM/height2 | >2 SD below reference population | 7.26 kg/m2 | 5.45 kg/m2 | Rosetta Study (1986–1992), 229 non-Hispanic white men and women aged 18–40 years | Baumgartner et al. 1998 |
B | ALM/height2 | Under 20th percentile | 7.25 kg/m2 | 5.67 kg/m2 | Health ABC Study (1997/1998), 2,976 men and women 70–79 years old black and white, Pittsburgh, Pennsylvania and Memphis, Tennessee | Delmonico et al. 2007 |
C | ALM/height2 | >2 SD below reference population | 6.19 kg/m2 | 4.73 kg/m2 | NHANES survey (1999–2004) white men and women aged 20 years | Kelly et al. 2009 |
D | Residuals of linear regression of ALM with height and fat mass | Under 20th percentile | NA | NA | NA | Delmonico et al. 2007 b |
E (1) (2) | Skeletal lean mass/body mass × 100% | 1–2 SD below reference population is class I sarcopenia >2 SD below reference population is class II sarcopenia | 37% 31% | 28% 22% | NHANES III (1988–1994), 6,414 men and women aged 18–39 years non-Hispanic white, non-Hispanic black and Mexican-American | Janssen et al. 2002 |
F (1) (2) | Skeletal lean mass/height2 | ROC analysis was used to develop cutpoints associated with moderate (1) and high (2) physical disability | 10.75 8.50 kg/m2 | 6.75 5.75 kg/m2 | NHANES III (1988–1994), 4,502 subjects aged 60 years plus, non-Hispanic white, non-Hispanic black and Mexican-American | Janssen et al. 2004 |
G | Optimal cutpoint for grip strength, identified in the ROC curve, predicting walking slower than 0.8 m/s | Below optimal cutpoint | 30.3 kg | 19.3 kg | InCHIANTI (1998–2000), 1,030 subjects aged 20–102 years, Tuscany, Italy | Lauretani et al. 2003 |
ALM appendicular lean mass, sum measurement of lean mass in all four limbs; ROC receiver operating characteristics; NA not applicable
aReference describes the formula and cut-off points, unless indicated otherwise
bReference describes the formula which was applied to the Leiden Longevity Study population